Novartis Agrees to $642 Million Settlement of Fraud Allegations
- July 10, 2020
Novartis Pharmaceuticals Corporation has agreed to pay over $642 million in separate settlements resolving claims that it violated the False Claims Act (FCA), the Department of Justice announced July 1.
ARTICLE TAGS
You must be logged in to access this content.